Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

This study investigated the “real-world” use of ranibizumab for neovascular age-related macular degeneration (nAMD) in Taiwan and assessed the visual outcome. We reviewed the medical records at National Cheng Kung University Hospital, Taiwan, during 2012–2014 for 264 consecutive eyes of 229 patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Chang, Yi-Sheng, Lee, Wan-Ju, Lim, Chen-Chee, Wang, Shih-Hao, Hsu, Sheng-Min, Chen, Yi-Chian, Cheng, Chia-Yi, Teng, Yu-Ti, Huang, Yi-Hsun, Lai, Chun-Chieh, Tseng, Sung-Huei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5945845/
https://ncbi.nlm.nih.gov/pubmed/29748599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-25864-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak